Massive health record study tests if new vaccine can stop pneumonia
NCT ID NCT07251465
Summary
This study aims to find out how well the PCV20 vaccine prevents pneumonia and other lung infections in adults who are at higher risk. Researchers will use existing health records from over 800,000 Kaiser Permanente members in Southern California, comparing infection rates between those who received the vaccine and those who did not. The study will follow people from 2022 to 2025 without actively enrolling new participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMONIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pfizer
New York, New York, 10001, United States
Conditions
Explore the condition pages connected to this study.